Literature DB >> 28160422

Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.

Kenei Furukawa1, Hiroaki Shiba1, Takashi Horiuchi1, Yoshihiro Shirai1, Koichiro Haruki1, Yuki Fujiwara1, Taro Sakamoto1, Takeshi Gocho1, Katsuhiko Yanaga1.   

Abstract

BACKGROUND: The Barcelona Clinic Liver Cancer (BCLC) classification is the most widely used staging system for hepatocellular carcinoma (HCC), but its prognostic ability in patients after resection has not been yet validated. The aim of this study was to evaluate the BCLC classification among patients after resection.
METHODS: The subjects were 196 patients who underwent hepatic resection for HCC between April 2003 and December 2014 at Jikei University Hospital. All patients were classified into a tumor stage according to the BCLC classification. Overall survival rate was calculated according to stages defined by the BCLC classification.
RESULTS: Overall survival rates at 1, 3 and 5-year were 100%, 95.2% and 95.2% in BCLC 0, 96.7%, 90.0% and 78.4% in BCLC A solitary, 86.2%, 86.2% and 86.2% in BCLC A multiple, 100.0%, 78.8% and 78.8% in BCLC B and 86.5%, 63.3% and 57.6% in BCLC C, respectively. Postoperative complications and mortality rates in relation to BCLC stage were comparable.
CONCLUSION: The BCLC treatment algorithm should consider the role of resection also for multiple early, intermediate and advanced stages.
© 2017 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Barcelona Clinic Liver Cancer classification; Hepatic resection; Hepatocellular carcinoma

Mesh:

Year:  2017        PMID: 28160422     DOI: 10.1002/jhbp.436

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  6 in total

1.  Clinical Relevance of Reductive Hepatectomy for Barcelona Clinic Liver Cancer Stages B and C Advanced Hepatocellular Carcinoma: A Single-Center Experience of 102 Patients.

Authors:  Shohei Komatsu; Masahiro Kido; Motofumi Tanaka; Kaori Kuramitsu; Daisuke Tsugawa; Masahide Awazu; Hidetoshi Gon; Hirochika Toyama; Kimihiko Ueno; Takumi Fukumoto
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Junjie Kong; Guangbing Li; Jiawei Chai; Guangsheng Yu; Yong Liu; Jun Liu
Journal:  Ann Surg Oncol       Date:  2021-06-23       Impact factor: 5.344

3.  Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.

Authors:  Han Wang; Peng-Cheng Du; Meng-Chao Wu; Wen-Ming Cong
Journal:  Hepatobiliary Surg Nutr       Date:  2018-12       Impact factor: 7.293

4.  Pretreatment risk management of a novel nomogram model for prediction of thoracoabdominal extrahepatic metastasis in primary hepatic carcinoma.

Authors:  Jia Hu; Ting Wang; Kun-He Zhang; Yi-Ping Jiang; Song Xu; Si-Hai Chen; Yu-Ting He; Hai-Liang Yuan; Yu-Qi Wang
Journal:  J Transl Med       Date:  2019-04-08       Impact factor: 5.531

5.  Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.

Authors:  Xubiao Wei; Yabo Jiang; Xiuping Zhang; Shuang Feng; Bin Zhou; Xiaofei Ye; Hui Xing; Ying Xu; Jie Shi; Weixing Guo; Dong Zhou; Hui Zhang; Huichuan Sun; Cheng Huang; Congde Lu; Yaxin Zheng; Yan Meng; Bin Huang; Wenming Cong; Wan Yee Lau; Shuqun Cheng
Journal:  J Clin Oncol       Date:  2019-07-08       Impact factor: 44.544

6.  New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.

Authors:  Hiroya Iida; Masaki Kaibori; Fumitoshi Hirokawa; Yoshihiro Inoue; Masaki Ueno; Kousuke Matsui; Morihiko Ishizaki; Shogo Tanaka; Shigekazu Takemura; Takeo Nomi; Daisuke Hokutou; Takehiro Noda; Hidetoshi Eguchi; Takuya Nakai; Hiromitsu Maehira; Haruki Mori; Masaji Tani; Shoji Kubo
Journal:  Asian Pac J Cancer Prev       Date:  2020-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.